System for applying electrical nerve stimulation, and method of applying electrical nerve stimulation

The system addresses the challenge of sensory effects in nerve stimulation by using a high-frequency component with a gradually increasing amplitude modulating envelope, achieving comfortable and sustained muscle contractions by desynchronizing nerve impulses.

WO2026234009A1PCT designated stage Publication Date: 2026-11-12OXFORD UNIVERSITY INNOVATION LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2026/062957
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-05-05
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing nerve stimulation systems, both implantable and non-implantable, face challenges in effectively stimulating motor nerves without causing strong sensory effects such as paraesthesia, especially when using high-frequency stimulation, as the neuromuscular junction cannot follow such frequencies, leading to unsustained muscle contractions and discomfort.

Method used

A system and method utilizing a high-frequency component modulated by a lower-frequency modulating envelope, with each pulse having a leading portion that gradually increases amplitude, allowing the neuromuscular junction to recover between packets, thereby reducing sensory effects and achieving sustained muscle contraction.

Benefits of technology

The described system effectively attenuates adverse sensory effects while providing strong and sustained muscle contractions by desynchronizing nerve impulses, enabling comfortable and efficient motor nerve stimulation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure EP2026062957_12112026_PF_FP_ABST
    Figure EP2026062957_12112026_PF_FP_ABST
Patent Text Reader

Abstract

Systems and methods for applying electrical nerve stimulation are disclosed. In one arrangement, a waveform generating unit generates an electrical waveform comprising a high frequency component and a lower frequency modulating envelope. The modulating envelope may define a sequence of pulses that each have a leading portion and a trailing portion. The leading portion of each pulse may comprise at least 5 periods of the high frequency component.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] SYSTEM FOR APPLYING ELECTRICAL NERVE STIMULATION, AND METHOD OF APPLYING ELECTRICAL NERVE STIMULATION

[0002] FIELD

[0003] The present disclosure relates to systems and methods for generating and / or applying electrical nerve stimulation. The disclosure is particularly applicable, for example, to transcutaneous nerve stimulation.

[0004] BACKGROUND

[0005] Nerve stimulators have been developed to provide stimulation to nerves. Implantable nerve stimulation systems generally have an implantable pulse generator and one or more leads that deliver electrical pulses to nerve tissue or muscle tissue. Non-implantable devices, such as standard TENS devices, which are different from those disclosed herein, are also marketed to treat nerves, but do not provide one or more of the specificity, functionality, stimulation parameters, sensors, feedback and / or therapeutic results generally needed for clinical efficacy in several aspects.

[0006] SUMMARY

[0007] Examples of systems for implementing transcutaneous nerve stimulation, such as for stimulating motor nerve fibres are described herein. A challenge that may be encountered when trying to stimulate motor nerve fibres from the skin surface is that there can be strong sensory effects at a lower threshold than the desired motor effects, causing onset of uncomfortable or painful sensations before muscle contraction. The sensory effects can result, for example, from (a) stimulation of sensory fibres in the same nerve as the motor fibres (this may be seen in ‘mixed nerves’ that contain both fibre types and may result in a strong paraesthesia in the nerve territory distally), and / or (b) stimulation of sensory fibres in the intervening skin underneath an electrode used to apply the simulation, which may be felt locally. Stimulation of mixed nerves with implanted rather than surface electrodes may produce (a) but not (b) in some embodiments of the disclosure.

[0008] Sensory fibre stimulation may be felt strongly when many fibres are firing synchronously. The perception may be greatly attenuated if the synchronisation is lost. One example of a way to make firing asynchronous is to use high frequency stimulus currents, at arate much higher than individual nerve fibres can follow. For example, one may implement a spinal cord stimulator system using continuous stimulation at a stimulation frequency of 10kHz for example, which permits effective analgesia without paraesthesia. However, such continuous high frequency stimulation may not be optimally suitable for motor stimulation because the neuromuscular junction (NMJ) cannot follow such high frequencies.

[0009] In accordance with several embodiments of the disclosure, improved systems and methods for generating and / or applying electrical nerve stimulation described herein may, for example, address one or more of the challenges mentioned above and / or other challenges.

[0010] According to an embodiment of the disclosure, there is provided a system for applying electrical nerve stimulation, comprising: a waveform generating unit configured to generate an electrical waveform; and an electrode arrangement for placement in electrical contact with a subject, the electrode arrangement configured to apply electrical stimulation to the subject based on the generated waveform, wherein: the generated waveform comprises a high frequency component and a lower frequency modulating envelope, the high frequency component has a dominant frequency of at least 500Hz, the modulating envelope defines a sequence of pulses, each pulse having a leading portion and a trailing portion, a duration of the leading portion of each pulse extends from a leading-portion-start time at which an amplitude of the pulse starts to rise from substantially zero to a leading-portion-end time at which the amplitude of the pulse first reaches a maximum amplitude of the pulse, and the leading portion of the pulse comprises (e.g., contains) at least 5 periods of the dominant frequency of the high frequency component.

[0011] Several embodiments disclosed herein are particularly useful for the treatment, mitigation or prevention of an airway disorder, a respiratory disorder and / or altering or maintaining the position of tongue tissue. In some embodiments, maintaining (e.g., enhancing, facilitating) an unobstructed airway during sleep is provided. In some embodiments, breathing is supported (e.g., healthy or desired breathing patterns, uninterrupted breathing, unobstructed breathing, etc.). Nerves (including but not limited to the hypoglossal nerve) and / or muscle tissue (including but not limited to the hypoglossus muscle) are stimulated (and / or detected) according to several embodiments.

[0012] Thus, in accordance with several embodiments of the disclosure, a system is provided that applies an electrical stimulation in the form of a high frequency component modulated bya modulating envelope that forms a sequence of pulses. Multiple electrical stimulations may be provided in each pulse at a frequency determined by the dominant frequency of the high frequency component. The modulating envelope may be shaped such that the amplitude of each pulse increases relatively gradually, which may cause the high frequency electrical stimulation to be applied with a correspondingly gradual increase of amplitude. Individual stimulation peaks corresponding to the high frequency component may be applied over a range of different amplitudes that gradually increase during each pulse.

[0013] It has been found by the inventors of the present application that high frequency stimulation can greatly attenuate adverse sensory effects when stimulating peripheral nerves. Continuously applied high frequency stimulation may not, however, yield optimally effective motor stimulation because the neuromuscular junction (NMJ) cannot respond quickly enough to follow the high frequency stimulation. The effect of these factors is that if high frequency stimulation is applied continuously, an initial muscle twitch is observed as the stimulation starts but a rapid relaxation is then observed as the high frequency stimulation has a blocking effect at the NMJ. Breaking the high frequency stimulation into packets (e.g., by providing a sequence of pulses in a modulating envelope) allows the NMJ to recover in between packets, which may result in at least one muscle activating pulse being transmitted per packet. High frequency stimulation delivered in such packets may produce strong and sustained muscle contraction. However, delivery of such packets can cause an unpleasant sensation due to a synchronised volley of nerve impulses being stimulated at the beginning of each packet.

[0014] In accordance with several embodiments of the disclosure, the shaping of the modulation envelope to gradually increase the amplitude of the high frequency component at the start of each pulse reduces or avoids such unpleasant sensation by spreading nerve stimulation out in time, which thereby suppresses or avoids any synchronised volley of nerve impulses at the start of each pulse. Without wishing to be bound by theory, it is thought that nerves will react to electrical stimulation over a range of different amplitudes, for example due to having a range of different individual thresholds, such that gradually increasing the amplitude of stimulations over time causes nerves to be stimulated over a corresponding range of different times.

[0015] The approach can be applied wherever it is desired to apply electrical stimulation with reduced adverse sensory effects. The applied electrical stimulation may for example be foreither or both of stimulating motor nerve fibres to cause muscle contraction and pain treatment (e.g., spinal cord stimulation).

[0016] Optionally, an average rate of increase of amplitude of the pulse during the leading portion is at least 10% of the maximum amplitude divided by the duration of the leading portion; and / or the amplitude of the pulse increases by less than 20% of the maximum amplitude of the pulse during each period of the high frequency component during the leading portion. Controlling the rate of increase of amplitude in the leading portions in these manners has been found to provide effective reduction or avoidance of unpleasant sensations at least in some embodiments.

[0017] Optionally, the duration of the trailing portion is smaller than the duration of the leading portion, optionally at least 10 times smaller. The shape of the trailing portion of each pulse may play a lesser or no role in reducing unpleasant sensation and can therefore be reduced in length without significantly reducing comfort for a user.

[0018] Reducing the duration of the trailing portion may, for example, allow the pulse to be made shorter, thereby saving power.

[0019] Optionally, the pulse duration of each pulse is at least 5 times smaller than an average pulse periodicity of the sequence of pulses (e.g., a mean average of the period of the sequence of pulses). Making the pulse duration relatively short in comparison with pulse periodicity has been found at least in some embodiments to provide a favourable balance of providing effective nerve stimulation and limiting power consumption.

[0020] Optionally, a second derivative of the amplitude of the pulse against time is positive for at least a majority of a first half of the duration of the leading portion. Gradually increasing the pulse amplitude in this manner has been found at least in some embodiments to provide particularly effective suppression of unpleasant sensations while providing effective motor nerve stimulation.

[0021] Optionally, at least the leading portion of each pulse comprises a portion of a Gaussian profile. Gradually increasing the pulse amplitude according to a Gaussian profile has been found at least in some embodiments to provide particularly effective suppression of unpleasant sensations while providing effective motor nerve stimulation. Other profiles may, however, be used, such as a Sigmoid profile (e.g.., such that each pulse comprises a portion or all of aSigmoid) or a linear ramp (e.g.„ such that each pulse comprises a linear portion with non-zero gradient).

[0022] According to several embodiments of the disclosure, there is provided a method of applying electrical nerve stimulation, comprising: using an electrode arrangement to apply electrical stimulation to a subject based on a generated waveform, wherein: the generated waveform comprises a high frequency component and a lower frequency modulating envelope, the high frequency component has a dominant frequency of at least 500Hz, wherein the modulating envelope defines a sequence of pulses, each pulse having a leading portion and a trailing portion, a duration of the leading portion of each pulse extends from a leading-portion-start time at which an amplitude of the pulse starts to rise from substantially zero to a leading-portion-end time at which the amplitude of the pulse first reaches a maximum amplitude of the pulse, and the leading portion of the pulse comprise (e.g., contains) at least 5 periods of the dominant frequency of the high frequency component.

[0023] According to several embodiments of the disclosure, there is provided a system for providing an electrical stimulation to a subject, the system comprising: a waveform generating unit, and an electrode operatively connected to the waveform generating unit and configured to provide an electrical stimulation to the subject, wherein the electrical stimulation comprises a high frequency component and a lower frequency modulating envelope, wherein the high frequency component has a dominant frequency of at least 500Hz, wherein the modulating envelope defines a pulse or sequence of pulses comprising a leading portion and a trailing portion, and wherein the leading portion of the pulse comprises at least 5 periods of the high frequency component.

[0024] According to several embodiments of the disclosure, there is provided a system for providing an electrical stimulation to a subject, the system comprising: an electrode, and a waveform generating unit comprising a processor configured to provide an electrical stimulation with the electrode to the subject, wherein the electrical stimulation comprises a high frequency component and a lower frequency modulating envelope, wherein the high frequency component has a dominant frequency of at least 500Hz, wherein the modulating envelope defines a pulse or sequence of pulses comprising a leading portion and a trailing portion, and wherein the leading portion of the pulse comprises at least 5 periods of the high frequency component.For purposes of summarizing the disclosure, certain aspects, advantages, and novel features are discussed herein. It is to be understood that not necessarily all such aspects, advantages, or features will be embodied in any particular embodiment of the disclosure. The disclosure herein supports a myriad of combinations of such aspects, advantages, or features.

[0025] BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Embodiments of the disclosure will now be further described, merely by way of example, with reference to the accompanying drawings. The illustrated figures are intended to illustrate, but not to limit, the embodiments of the disclosure. Various features of the different disclosed figures can be combined to form further embodiments, which are part of this disclosure.

[0027] Figure 1 schematically depicts a system for applying electrical nerve stimulation to a subject based on a generated waveform, according to one embodiment of the disclosure.

[0028] Figure 2 schematically depicts a generated waveform according to one embodiment of the disclosure. The upper portion of the figure shows three example pulses of the generated waveform with the vertical direction representing voltage and the horizonal direction representing time. The lower portion of the figure shows a magnified view of a portion of one of the pulses shown in the upper portion of Figure 2.

[0029] Figure 3 depicts a magnified version of a modulating envelope corresponding to the generated waveform shown in Figure 2 according to one embodiment of the disclosure.

[0030] Figure 4(a) shows an example high frequency component of a generated waveform, with the vertical direction representing voltage and the horizonal direction representing time.

[0031] Figures 4(b)-4(g) show example pulses of different modulating envelopes with a horizontal time axis having the same scale as Figure 4(a) to allow comparison between shapes of the pulses 21 and the high frequency component of Figure 4(a).

[0032] Figure 5 depicts a range of example waveforms for electrical nerve stimulation.

[0033] Figure 6 is a graph showing experimentally observed discomfort windows for each of the waveforms of Figure 5.

[0034] Figure 7 is a graph showing experimentally observed pain windows for each of the waveforms of Figure 5.Figure 8 is a graph showing experimentally observed displacements of the hyoid for nine different subjects (participants) caused by electrical stimulation applied using an embodiment of the method of the present disclosure.

[0035] DETAILED DESCRIPTION

[0036] Several embodiments described herein relate to stimulation of nerves and / or muscles using, for example, a waveform comprising a high frequency component and a lower frequency modulating envelope. For example, several embodiments disclosed herein relate to stimulation of nerves and / or muscles using, for example, such a waveform to treat, mitigate or prevent one or more of an airway disorder or a respiratory disorder and / or to alter or maintain a position of at least a portion of a tongue (e.g., muscle or other tissue of the tongue). In accordance with several embodiments, stimulation of nerves and / or muscles using, for example, such a waveform may advantageously be configured to maintain (e.g., enhance, improve, facilitate) an unobstructed airway (e.g., prevent obstruction of the airway) during sleep. In accordance with several embodiments, stimulation of nerves and / or muscles using, for example, such a waveform provides supported breathing (e.g., healthy or desired breathing patterns, uninterrupted breathing, consistency in breathing, unobstructed breathing, etc.). Nerves (including but not limited to the hypoglossal nerve) and / or muscle tissue (including but not limited to the hypoglossus muscle) are modulated (e.g., stimulated) and / or nerve or muscle activity is detected according to several embodiments.

[0037] In the present disclosure, any reference to an average may be understood to refer to a mean average.

[0038] Figure 1 schematically depicts an example system 2 for applying electrical nerve stimulation to a subject 4. The system 2 comprises a waveform generating unit 6. The waveform generating unit 6 is configured to generate an electrical waveform 8 (e.g., see Figure 2). The waveform generating unit 6 may comprise any suitable combination of components that is capable of providing the required functionality, including electronic components and / or power supplies and / or data processing hardware, firmware and / or software. The waveform generating unit 6 may thus, for example, comprise a processor configured to provide the electrical stimulation to the subject. The waveform generating unit 6 may be configured to perform computer-implemented methods. Each step of such methods may be performed by a computer in the most general sense of the term, meaning any device capable of performing thedata processing steps of the method, including dedicated digital circuits. The computer may comprise various combinations of computer hardware, including for example CPUs, RAM, SSDs, motherboards, network connections, firmware, software, and / or other elements that allow the computer hardware to perform the required and / or desired computing operations. The required and / or desired computing operations may be defined by one or more computer programs. The one or more computer programs may be provided in the form of media or data carriers, optionally non-transitory media, storing computer readable instructions. When the computer readable instructions are read by the computer, the computer performs the required and / or desired method steps. The computer may comprise (e.g., consist) of a self-contained unit, such as a general-purpose desktop computer, laptop, tablet, mobile telephone, or other smart device. Alternatively, the computer may comprise (e.g., consist) of a distributed computing system having plural different computers connected to each other via a network such as the internet or an intranet.

[0039] The system 2 further comprises an electrode arrangement 10. In the example shown, the electrode arrangement 10 comprises two electrodes 12 but more than two electrodes may be provided, for example to provide a regular or irregular array of electrodes. Each electrode 12 may optionally comprise two or more sub-electrodes, such as sub-electrodes arranged concentrically relative to each other or two or more sub-electrodes arranged in a regular or irregular array of sub -electrodes. In some embodiments, each electrode 12 is operatively coupled to the waveform generating unit 6. The electrode arrangement 10 is configured for placement in electrical contact with a subject (e.g., a human or animal) to which the electrical nerve stimulation is to be applied, for example with electrodes 12 of the electrode arrangement 10 in contact with skin 14 of the subject 4 as exemplified in Figure 1, for example when used to implement transcutaneous stimulation, or in contact with tissue underneath the skin, for example when used with implanted electrodes. In some embodiments, the electrode arrangement 10 is configured to apply electrical stimulation to the subject 4 based on the generated waveform 8 (e.g., to apply a current having an amplitude that varies in the same way as a function of time as the generated waveform 8). The electrode arrangement 10 may be configured for example to receive the generated waveform 8 from the waveform generating unit 6, for example via one or more input electrical leads, and transfer the generated waveform8 to the subject 4 via electrical conduction of the generated waveform 8 to one or more electrodes 12 of the electrode arrangement 10 that electrically contact the subject 4.

[0040] Reference is now made to an example generated waveform 8 shown in Figure 2. The vertical direction represents a voltage of the generated waveform 8. The horizontal direction represents time. The upper portion of the figure shows three example pulses 21 of the generated waveform 8. In this example the pulses 21 have identical shapes but this is not essential: in other implementations pulses 21 having multiple different shapes may be provided, for example alternating between a first shape and a second shape. The lower portion of the figure shows a magnified view of a portion of one of the pulses 21 shown in the upper portion of the figure that is within the smaller broken line box. As exemplified in Figure 2, the generated waveform 8 comprises a high frequency component 22 (visible in the magnified view) and a lower frequency modulating envelope 23 (defining the outer shape of the generated waveform 8 shown in the upper portion of the figure). The high frequency component may take any suitable form: e.g., sinusoidal, square wave, etc. The generated waveform 8 may be defined, for example, by multiplying a function representing the high frequency component 22 by a function representing the modulating envelope 23.

[0041] In several embodiments, the high frequency component has a dominant frequency of at least 500Hz, optionally at least 1kHz, optionally at least 5kHz, optionally at least 8kHz.

[0042] In some embodiments, the modulating envelope 23 defines a sequence of pulses 21. In some embodiments, the modulating envelope 23 defines a maximum possible amplitude of the generated waveform 8 at any point of time. For example, the amplitude of the generated waveform 8 may not exceed the amplitude of the modulating envelope. For example, if the generated waveform 8 is defined by applying the modulating envelope to a sinusoidal signal, the amplitude of the sinusoidal signal will be modulated to be equal to the amplitude of the modulating envelope at all points in time. The sequence of pulses 21 may comprise a regular (evenly spaced) sequence. The frequency of the sequence of pulses may be much less than the dominant frequency of the high frequency component. The frequency of the sequence of pulses may, for example, be less than about 200Hz, optionally less than about 100Hz, optionally less than 75Hz. The frequency of the sequence of pulses may for example be in the range of 20Hz to 100Hz, optionally in the range of 20Hz to 80Hz, optionally in the range of 20Hz to 60Hz,optionally in the range of 30Hz to 50Hz. In the “Wavelet” example discussed below with reference to Figures 5-7, the frequency of the sequence of pulses is 40Hz.

[0043] The dominant frequency of the high frequency component may be associated, for example, with a largest peak in a frequency (e.g., Fourier) spectrum of the generated waveform 8 above a frequency associated with the separation in time between the pulses in the sequence and / or a low (e.g., 1st, 2ndor 3rd) harmonic thereof.

[0044] Reference is now made to Figure 3, which shows a magnified version of the modulating envelope 23 of the example generated waveform 8 of Figure 2. The vertical axis represents an amplitude of the modulating envelope 23. The horizontal direction represents time. Each pulse 21 in the sequence has a leading portion 31 and a trailing portion 32.

[0045] A duration 311 of the leading portion 31 of each pulse 21 extends from a leading-portion-start time 312 to a leading-portion-end time 313. The leading-portion-start time 312 is a time at which an amplitude of the pulse 21 starts to rise from substantially zero. The leading-portion-end time 313 is a time at which the amplitude of the pulse 21 first reaches a maximum amplitude Vm of the pulse 21. Substantially zero in this context may be defined as less than 0.01% of the maximum amplitude Vm.

[0046] A duration of the trailing portion 32 of each pulse 21 extends from a trailing -portion-start time 322 (which is the same as the leading-portion-end time 313 in the example of Figure 3 but this is not necessarily the case) to a trailing-porti on-end time 323. The trailing-porti on-start time 322 is a time at which the amplitude of the pulse 21 is last at the maximum amplitude Vm of the pulse 21. In some embodiments, the trailing-porti on-end time 323 is a time at which the amplitude of the pulse 21 first reaches substantially zero again.

[0047] The pulse duration 211 of each pulse 21 may be defined as the time between the leading-portion-start time 312 and the trailing-portion-end time 323, as depicted in Figure 3. In some implementations, the pulse duration 211 is relatively small in comparison to an average pulse periodicity 212 of the sequence of pulses 21, optionally at least 5 times smaller, optionally at least 10 times smaller, optionally at least 25 times smaller, optionally at least 50 times smaller, optionally at least 100 times smaller. The pulse periodicity is defined as the separation in time between equivalent portions of temporally adjacent pulses, such as the separation in time between the leading-portion-end time 313 of one pulse and the leading-portion-end time 313 of an adjacent earlier or later pulse (as labelled in Figure 3).The pulse duration 211 of each pulse 21 may be at least 5 times longer, optionally at least 10 times longer, optionally at least 50 times longer, optionally at least 100 times longer, than the period of the dominant frequency of the high frequency component 22.

[0048] The pulse duration 211 of each pulse 21 may, for example, be at least 500 microseconds, optionally at least 5000 microseconds, optionally at least 50000 microseconds.

[0049] The dominant frequency of the high frequency component may be less than 20kHz, optionally less than 10kHz, optionally less than 5kHz.

[0050] In several embodiments, the leading portion 31 of the pulse 21 comprises (e.g., contains) at least 5 periods, optionally at least 10 periods, optionally at least 50 periods, optionally at least 100 periods, of the dominant frequency of the high frequency component. In some embodiments, the amplitude of each pulse 21 increases relatively gradually during the leading portion 31. The leading portion 31 of the pulse 21 may therefore be a portion of the pulse 21 during which the modulating envelope continuously increases in amplitude. The continuous increase in amplitude may, in accordance with several embodiments, be configured to be gradual enough to reduce or avoid discomfort by reducing or avoiding synchronised nerve stimulation. The electrical stimulation may thus, in several embodiments, be configured to produce a sustained muscle contraction with minimal synchronised nerve stimulation when the electrical stimulation is provided to the subject.

[0051] The gradual increase in amplitude may be quantified, for example, by the following first criterion: an average rate of increase of amplitude of the pulse 21 (and therefore of the modulating envelope) during the leading portion 31 being at least 10%, optionally at least 20%, optionally at least 30%, optionally at least 50%, optionally at least 75%, of the maximum amplitude Vm divided by the duration 311 of the leading portion 31.

[0052] Alternatively or additionally, the gradual increase in amplitude may be quantified, for example, by the following second criterion: the amplitude of the pulse (and therefore of the modulating envelope) increases by less than 20%, optionally less than 10%, optionally less than 5%, optionally less than 2%, optionally less than 1%, of the maximum amplitude Vm of the pulse 21 during each period of the high frequency component during the leading portion 31.

[0053] In some embodiments, the first and second criteria exclude configurations in which the amplitude rises by a significant proportion of the maximum amplitude Vm relatively abruptlyduring the leading portion 31. In some embodiments, this may result in the gradient being relatively flat for the rest of the leading portion 31, leading to an average rate of increase of amplitude of the pulse 21 during the leading portion 31 that is lower than required to satisfy the first criterion (e.g., lower than 10% of the maximum amplitude Vm divided by the duration 311 of the leading portion 31). Such an abrupt increase in amplitude may also fail the second criterion if it resulted in the amplitude rising by more than 20% of the maximum amplitude Vm during any period of the high frequency component during the leading portion.

[0054] Figure 4(a) depicts an example high frequency component 22 of a generated waveform. Figures 4(b)-(g) show example pulses 21, 211 of different modulating envelopes with a horizontal time axis having the same scale as Figure 4(a) to allow comparison between shapes of the pulses 21, 211 and the high frequency component 22 of Figure 4(a).

[0055] Figures 4(b) and 4(c) depict example pulses 211 that would not satisfy either of the first criterion and the second criterion mentioned above when applied to the high frequency component of Figure 4(a). In the example of Figure 4(b), the pulse 211 is a square wave comprising an extremely short leading portion, which would result in an excessively abrupt increase in amplitude. In the example of Figure 4(c), the pulse 211 has a Gaussian-like leading portion, but the duration of the Gaussian-like form is too short to prevent an excessively abrupt increase in amplitude. Comparison to the high frequency component in Figure 4(a) shows that the leading portion of the pulse 211 does not contain at least 5 periods of the dominant frequency. In accordance with several embodiments, a pulse 211 of the form shown in Figure 4(b) could only satisfy the first criterion and the second criterion when applied to a high frequency component having a much higher dominant frequency than the high frequency component 21 shown in Figure 4(a).

[0056] Figures 4(d), 4(e), 4(f), and 4(g) show example pulses 21 that all satisfy both of the first and second criteria, in accordance with several embodiments of the disclosure.

[0057] In the example of Figure 4(d), the pulse 21 has a Gaussian form with a large enough width to satisfy the first and second criteria when applied to the high frequency component of Figure 4(a) (or any high frequency component 22 having a higher dominant frequency), in accordance with several embodiments of the disclosure.

[0058] In the example of Figure 4(e), the pulse 21 has a triangular form, with a constant positive gradient during the leading portion 31 and constant equal and opposite negativegradient during a trailing portion 32. The gradient is shallow enough for the first and second criteria to be satisfied, in accordance with several embodiments of the disclosure.

[0059] Figures 4(f) and 4(g) show example pulses 21 that are asymmetric along the time axis, with a leading portion 31 that is shallow enough to satisfy the first and second criteria and a trailing portion 32 that is more abrupt, in accordance with several embodiments of the disclosure. In the example of Figure 4(f), the trailing portion 32 is extremely short, resembling the end of a square wave. In the example of Figure 4(g), the trailing portion 32 is longer than the trailing portion 32 in Figure 4(f) but considerably shorter than the leading portion 31. In the examples of Figures 4(f) and 4(g), the leading portion 31 has a Gaussian-like form but any other shape that satisfies the first and second criteria could be used. These pulses 21 are examples of a broader class of implementation in which the duration of the trailing portion 32 of a pulse 21 is smaller than the duration of the leading portion 31 of the pulse 21, optionally at least 10 times smaller, optionally at least 25 times smaller, optionally at least 50 times smaller, optionally at least 100 times smaller.

[0060] In some implementations, as shown in the Gaussian forms shown in Figures 2, 3, 4(d), 4(f) and 4(g), a second derivative of the amplitude of each pulse 21 against time is non -zero (i.e., the amplitude follows a non-linear variation as a function of time) for at least a majority of the duration of the leading portion 31. The second derivative of the amplitude of the pulse 21 against time may, for example, be positive (e.g., curving upwards with progressively increasing gradient) for at least a majority (optionally all) of a first half of the duration of the leading portion 31, which is the case for example in the Gaussian profiles of Figures 2, 3, 4(d), 4(f) and 4(g). The second derivative of the amplitude of the pulse against time may be negative (e.g., curving upwards with progressively decreasing gradient) for at least a majority (optionally all) of a second half of the duration of the leading portion 31, which is also the case for example in the Gaussian profiles of Figures 2, 3, 4(d), 4(f) and 4(g). At least the leading portion 31 of each pulse 21 may thus comprise a portion of a Gaussian.

[0061] Alternatively, as shown in Figure 4(e), a second derivative of the amplitude of the pulse 21 against time may be substantially zero for at least a majority (optionally all) of the duration of the leading portion 31.

[0062] In some implementations, as shown in Figures 2, 3, and 4(d)-(g), for each pulse the amplitude of the pulse 21 increases monotonically during the leading portion 31 (i.e., duringall of the leading portion 31) of the pulse 21. Additionally or alternatively, the amplitude of the pulse 21 may decrease monotonically during the trailing portion 32 (e.g., during all of the trailing portion 32) of the pulse 21.

[0063] EXAMPLES

[0064] The following are non-limiting descriptions of experimental methods, devices and parameters that were used in examples disclosed below.

[0065] Comparison with other waveforms

[0066] Figure 5 depicts a range of waveforms for applying electrical nerve stimulation.

[0067] The “Wavelet” waveform is an example of a waveform of the type discussed above with reference to Figures 2, 3 and 4(d), in accordance with several embodiments. The waveform is defined by a modulating envelope comprising pulses having a Gaussian form. The graphs show an example 75ms interval. Captions include the total charge passed in one second at 50mA.

[0068] The following table provides parameters of the waveforms shown in Figure 5.

[0069] WAVEFORM KEY PARAMETERS TONIC 40Hz, biphasic, lOOps per phase CONTINUOUS HF 10kHz, biphasic, 30ps per phase

[0070] BURST 40Hz inter-burst, 500Hz intra-burst, 5 monophasic pulses per burst, 1ms pulse width, exponential recovery phase

[0071]

[0072] CLUSTERED TONIC 40Hz inter-burst, 500Hz intra-burst, 5 biphasic pulses per burst,

[0073] 1ms per phase

[0074] SINUSOIDAL 2kHz sine

[0075] RUSSIAN 2kHz sine, 40Hz burst frequency, 10ms burst width WAVELET 2kHz intra-wavelet, 40Hz inter- wavelet, 10ms width at halfmax

[0076] OFFSET WAVELET 2kHz intra-wavelet, 40Hz inter- wavelet, 10ms width at halfmax, 40Hz modulating frequencyTo test the different waveforms, the inventors developed a system that allows arbitrary waveforms to be delivered accurately. The above eight waveforms were delivered to subjects using the system. The eight waveforms include waveforms that are used by existing neuromodulation devices (“Continuous HF”, “Burst” and “Clustered Tonic”). 10 participants were each exposed to all waveforms in a randomised, blinded fashion and the point at which they experienced perception of stimulation, paraesthesia, motor activity, discomfort (“I would not want this for a very long time but it is tolerable”) and pain (“stop this now and do not do that again”) were measured. The factors contributing to the limiting pain were then characterised - pain under the electrode, painful paraesthesia, painful motor contraction.

[0077] The study showed that it is possible to achieve motor activity without pain or discomfort. There is a range of stimulation amplitudes within which stimulation without pain is achievable for all of the waveforms tested, though the size of this range differs significantly between waveforms. Not all waveforms can achieve motor activity without discomfort - this was restricted to Continuous HF and Wavelet. These results demonstrate that there are significant differences in the effects of different waveforms.

[0078] The waveforms tested differ greatly in the amount of charge delivered in a given unit of time: the “dose” of electricity applied. For example, a burst waveform at 40Hz delivers five times as much charge as a tonic waveform at the same frequency and amplitude. It may not be a fair comparison to compare on the basis of amplitude alone. The inventors therefore compared all waveforms by measuring the activation thresholds in terms of the total charge delivered to achieve an effect. They showed that even when comparing on the basis of charge delivery, there remains significant differences between waveforms. This suggests that the waveform shape has importance to the effect achieved beyond simply as a means of charge delivery. Note also that when comparing charge delivery, only the Continuous HF and Wavelet stimulation have ranges within which motor activity without discomfort is achievable.

[0079] The inventors investigated whether the observed differences may be due to differing duty cycles, i.e., the proportion of time during which stimulation is turned on. It may be that waveforms with a high duty cycle may be delivering the same charge over a greater time, therefore requiring a lower peak amplitude, which may be more comfortable. The duty cycle (adapted to account for non-square waveforms) was calculated and it was found that it is not significantly related to the ability to achieve motor activity without pain or discomfort.This suggests that actual waveform features do have a significant impact on the effects achieved, in accordance with several embodiments disclosed herein. The effect of stimulation frequency on therapeutic window was investigated and it was found that there is a significant relationship between stimulation frequency and the ability to achieve motor activity without pain or discomfort. Notably, there is a major increase in window size (i.e., the range of amplitudes for which motor activity is achieved without pain or discomfort) when frequency is increased into the kHz range. This demonstrates that there is a change in how the nerve is responding to stimulation as the frequency is increased. Without wishing to be bound by theory, it is believed that the effect may be related to desynchronisation of activity when frequency is raised above the rate at which neurons can respond to stimulation.

[0080] However, the inventors also observed that when Continuous HF (10kHz) is applied continuously, although motor activity is produced, this response fades quickly rather than producing a sustained contraction as in other waveforms. This appears to be due to the neuromuscular junction and / or muscle contractile apparatus being unable to follow such high frequencies.

[0081] Simulation using the Wavelet waveform consistently demonstrated good windows. This waveform was designed based on considerations around how nerves respond to stimulation. The inventors tested the Wavelet waveform with a 10kHz internal frequency (i.e., a high frequency component having a dominant frequency of 10kHz) while maintaining the modulation (i.e., a lower frequency modulating envelope having a Gaussian form). In the inventors’ tests, this produced very comfortable stimulation analogous to the Continuous HF, but with a sustained motor contraction. It is thought that the Wavelet waveform takes advantage of the sensory desynchronisation effects of high-frequency stimulation (via the high frequency component) while the lower frequency modulating envelope maintains the motor effect.

[0082] Figure 6 shows discomfort windows for the waveforms of Figure 5. The inventors found that it is possible to achieve motor activation without discomfort in only some of the waveforms. The discomfort threshold is shown as a proportion of the motor threshold and therefore labelled as a “relative” window. There are statistically significant differences in window sizes between waveforms (ANOVA, F = 2.4104, p = 0.0288). Short dashed linesindicate mean values of the window (relative) and short grey dotted lines indicate one standard deviation away from the mean.

[0083] Figure 7 shows pain windows for the waveforms of Figure 5. The inventors found that it is possible to achieve motor activation without pain in all waveforms, in accordance with several embodiments disclosed herein. The pain threshold is shown as a proportion of the motor threshold and therefore labelled as a “relative” window. There are statistically significant differences in window sizes between waveforms (ANOVA, F = 7.4863, p < 0.0001). Short dashed lines indicate mean values of the window (relative) and short grey dotted lines indicate one standard deviation away from the mean.

[0084] Figures 6 and 7 show the discomfort or pain threshold divided by the motor threshold, which means that data points to the right of x=l are desirable because they correspond to achieving motor activation without side effect. Only the Wavelet and Continuous HF waveforms achieved data points (participants) that are all to the right of the x=l line, and as described already, Continuous HF is not useful for motor stimulation because it does not provide a sustained motor contraction (it causes only a brief twitch and then relaxation).

[0085] Limiting factors for stimulation were also characterised. Notably, paraesthesia pain was found to be the limiting factor in >75% of cases. If one is targeting a purely motor nerve rather than a mixed nerve, paraesthesia is not an issue and it is likely that larger windows can be achieved.

[0086] Overall, these results demonstrated that:

[0087] • Motor activity without pain or discomfort is possible

[0088] • Differences between waveforms are due to intrinsic waveform features

[0089] • High frequency stimulation is more comfortable, but loses motor effects quickly

[0090] Waveforms of several embodiments of the present disclosure use these insights to allow comfortable stimulation with sustained motor responses.

[0091] Non-invasive neurostimulation of the hypoglossal nerve and hyoid bone elevation

[0092] The inventors have demonstrated use of several embodiments of systems and methods of the present disclosure in the context of non-invasive neurostimulation of the hypoglossal nerve.Obstructive sleep apnea (OSA) is a significant clinical problem. It is responsible for a significant amount of morbidity. It is common. It produces major detrimental effects on quality of life and wellbeing and is linked to significantly worse health outcomes, including worsened cardiovascular disease. It is caused by intermittent obstruction of the airway while sleeping. This interrupts breathing, producing episodes of apnea. This causes the patient to wake from sleep, interrupting normal sleeping. This obstruction is caused by a variety of factors, including loss of tone in the tongue and muscles surrounding the airway causing this to move backwards and partially obstruct the airway.

[0093] There are little in the way of specific treatments for obstructive sleep apnea. The mainstay of treatment is lifestyle adjustment and weight loss to keep the airway open during sleep. In more severe cases, continuous positive airways pressure (CPAP) systems are worn overnight to artificially provide high airway pressures to hold the airways open. This requires wearing a tightly fitting mask overnight and is highly disruptive to patients and their families.

[0094] Recently, new specific treatment options have emerged. These include implanted electrical stimulators targeting the hypoglossal nerve. By stimulating this nerve, the tongue musculature is forced to contract, opening the airway. This has shown some success but is limited by the risks of the surgical procedure, restricting application.

[0095] The inventors experimentally investigated application of waveforms in accordance with several embodiments of the present disclosure to achieve non-invasive stimulation of the hypoglossal nerve for application to patients with obstructive sleep apnea to maintain airway patency during sleep without the need for ventilation or surgery.

[0096] Healthy volunteers with no respiratory or neurological pathologies were recruited. The study was approved by the University of Oxford Central University Research Ethics Committee.

[0097] Electrode pairs were placed symmetrically on each side of the head. Cathodes were positioned just medial to the angle of the mandible with anodes positioned just lateral to the midline, immediately posterior to the inferior border of the mandible. This electrode arrangement produces an electric field which varies primarily along the axis of the hypoglossal nerve in its extracranial course. This allows for maximal activation of the nerve, in accordance with several embodiments disclosed herein.The hypoglossal is located deep to muscle during much of its course in the floor of the jaw. The location of the electrodes was chosen because as the hypoglossal (XII) nerve passes medial to the angle of the jaw anterior to the carotid arteries, the nerve lies relatively superficial to the skin (cathode). The anode was placed in the vicinity of the bifurcation of the XII nerve immediately lateral to the anterior digastric belly deep to the mylohyoid muscle, in line with the premolar teeth. The XII nerve is deep to muscle in this location but this landmark is where the nerve is most superficial anteriorly, giving the best opportunity to stimulate the fibres innervating the bulk of the musculature of the anterior tongue (inc. genioglossus).

[0098] Stimulation was applied using two stimulators. One stimulator was used for each electrode pair, providing an independent current source for each side. This ensures reliable bilateral activation, even with differences in electrode impedances between sides.

[0099] A stimulation waveform of the Wavelet type (e.g., such as described above with reference to Figures 2, 3, 4(d), and 5) was applied to maximize motor activation with minimal discomfort. The waveform is defined by a modulating envelope comprising pulses having a Gaussian form. In this example, the waveform comprises a sinusoidal high frequency component having a frequency of 10kHz (to minimize discomfort), modulated by a lower frequency modulating envelope having a Gaussian waveform with a packet frequency of 40Hz (to produce effective motor activation).

[0100] The stimulation waveform was produced by a custom hardware system which controlled the stimulators. The experimental protocol was run on a laptop using custom software which determined the amplitude applied by the hardware system.

[0101] Activation of hypoglossal structures was determined using measurement of tongue diameter. When the hypoglossal -innervated intrinsic tongue muscles contract due to activation, the tongue diameter increases.

[0102] A standard clinical ultrasound system was used. A linear probe was placed in the midline, just posterior to the border of the mandible in a sagittal orientation with the posterior edge of the mandible’s acoustic shadow just visible in the anterior portion of the imaging window. The tongue diameter was measured from the skin surface to the maximal curvature of the tongue-air interface.

[0103] Participants were positioned supine on an examination bed. Self-adhesive gel electrodes were placed at the target locations with no skin preparation. Stimulation was turnedon and the amplitude of stimulation was gradually increased until the participant’s individual tolerance threshold was determined. This was defined as the first amplitude where they experience pain or significant discomfort that they would not be happy to have applied continuously.

[0104] Stimulation was then applied at intervals between 0 and 100% of the maximum amplitude for that individual. Intervals of 0%, 20%, 40%, 60%, 80% and 100% were tested. When stimulation was applied, the tongue diameter was measured and recorded.

[0105] The order of presentation of stimulation amplitudes was randomized and the team carrying out the experiment was blinded to the amplitude applied. Ten sets of measures were taken, each comprising all intervals in a randomized order. This minimized bias in results with randomization and blinding, accounted for variance in recorded measures by taking many measures at each interval and limited the impact of shifts in baseline measures and changes in the imaging window over time by randomizing in blocks.

[0106] Ten participants were recruits (eight male, two female). The mean age of participants was 35.5 + / - 7.2 years (range 26 - 46). The mean tolerance threshold was 30.7 + / - 7.3mA (range 20 - 40mA).

[0107] Stimulation was found to produce a measurable change in tongue diameter in most participants. Nearly all participants showed a clear increase in tongue diameter with increasing stimulation amplitude. This suggests that electrical stimulation can produce a measurable muscle contraction non-invasively. These effects were achieved without any specific skin preparation using simple anatomical landmarks for electrode positioning. This shows that reliable motor activation can be achieved non-invasively without the need for time-consuming or complex procedures prior to using the system, in accordance with several embodiments disclosed herein. This suggests that this approach may be suitable for application in an unsupervised setting, with electrodes simply applied to unprepared skin.

[0108] Stimulation was generally well tolerated by participants. Initial titration to individual tolerance limits allowed testing within comfort levels for all participants. Many participants found the sensation produced by prolonged stimulation unusual. This sensation was due to tetanic contraction of the muscles of the floor of the mouth and the neck at high stimulation amplitudes. This sustained muscle contraction usually occurred prior to the stimulation becoming painful or excessively uncomfortable. The limiting factor for most participants wasthe sustained muscle contraction becoming painful, which supports motor activation being possible prior to the point of discomfort.

[0109] Some participants found the sensation of muscle contraction sufficiently uncomfortable that this limited the stimulation amplitude that was applied. This resulted in only seeing a measurable response very close to the tolerance limit. However, nearly all participants reported feeling more comfortable with stimulation following the period of testing. This suggests that participants may adapt rapidly to the unusual sensation of hypoglossal-innervated muscle contraction, increasing tolerance. In accordance with several embodiments, it may be useful therefore to include a period of exposure to the sensation of muscle contraction prior to titration of tolerance levels in order to allow better distinction between the feeling of muscle contraction which is unusual but desirable for effect and muscle contraction which is excessive and painful.

[0110] The hyoid bone is located superiorly in the pharynx and has extensive muscular attachments to the floor of the month and the thyroid cartilage. The muscular attachments are divided into the suprahyoid and infrahyoid groups. Suprahyoid muscles include the mylohyoid, anterior belly of the digastric, stylohyoid and geniohyoid muscles. The nerve supply of these muscles is from several different cranial nerves including the hypoglossal nerve (geniohyoid muscle). These muscles tend to act as a functional unit with the infrahyoid muscles (not described here) performing actions including elevation of the hyoid bone. Hyoid bone elevation has the effect of altering the size and shape of the airway, which can be used to treat obstructive sleep apnea.

[0111] It is possible to surgically elevate the hyoid to treat obstructive sleep apnea, but surgery carries risks.

[0112] The inventors investigated whether the tongue contraction discussed above is associated with hyoid bone elevation and, therefore, whether the hypoglossal nerve stimulation can have a direct effect on airway calibre.

[0113] The following data were acquired in 9 subjects undergoing bilateral bipolar stimulation using the Wavelet waveform of the hypoglossal nerve at approximately 80% (and in one case 40%) of maximally tolerated stimulation amplitude (in mA). One subject was excluded as there was no effect on tongue contraction or hyoid bone elevation at maximally tolerated stimulation. The maximum tolerated amplitude in each subject was defined prior to measurement of hyoid bone elevation by monotonically increasing stimulation amplitude until the subject found thestimulation to be intolerable. The relative displacement of the hyoid bone was measured using dynamic B-mode ultrasound. Before each stimulus, the resting position of the hyoid bone was defined as Omm, then the position of the hyoid upon stimulation was measured relative to 0mm by the experimenter. The Omm was the position of the superior anterior corner of the hyoid bone hyperintensity. This was re-zeroed before each stimulus because the hyoid bone is highly mobile and often did not return to a fixed position after each stimulus. Limitations of the ultrasound probe prevented measurement of hyo-mental distance.

[0114] Descriptive statistics were generated to describe the mean and standard deviation of hyoid bone elevation (HBE) in each subject. A single predictor (stimulation amplitude), linear regression model was used to study the relationship between stimulation and HBE in mm.

[0115] Figure 8 shows results from 9 subjects who tolerated sufficient stimulation to cause tongue contraction. Overall, 9 subjects completed the protocol yielding 150 trials of stimulation vs HBE. Presented here are results of HBE on stimulus individual trials by participant and results of linear regression between the input (predictor) variable stimulation current amplitude and the output (response) variable HBE in mm, using a simple linear regression model y ~ 1 + x across 5 subjects who underwent 6 trials. The input variable ranged from 7mA to 30mA. The figure shows HBE in 9 subjects at 80% of maximum tolerated stimulus amplitude. Displacement indicates the movement of the hyoid superiorly and anteriorly upon 3 s of bipolar stimulation at an intensity of 80% of maximum tolerated stimulation relative to Omm. Mean HBE = 3.4mm + / - 1.9, range -1mm to +9.1mm. Long dashed lines indicate mean values of the displacement and short dashed lines indicate one standard deviation away from the mean.

[0116] The results indicate that hypoglossal stimulation is associated with hyoid bone elevation. HBE was achieved at similar intensities in subjects that were associated with tongue contraction (e.g., 20-40mA). The data indicates there is a relative elevation of the hyoid bone superiorly and anteriorly with hypoglossal stimulation using several embodiments of the method of the present disclosure.

[0117] The overall trends in the HBE data are that even low stimulation amplitudes (e.g., <20mA) are associated with elevation of the hyoid and that in the small group there was a dose - response effect on HBE with increasing amplitudes of stimulation.This study demonstrates that hypoglossal nerve stimulation using several embodiments of the systems and methods of the present disclosure has a physiological effect that could be used as the basis for treating OSA.

[0118] Additional Considerations and Terminology

[0119] Conditional language used herein, such as, among others, "can," "could," "might," "may," “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain features, elements, and / or steps are optional. Thus, such conditional language is not generally intended to imply that features, elements, and / or steps are in any way required or that one or more embodiments necessarily include logic for deciding, with or without other input or prompting, whether these features, elements, and / or steps are included or are to be always performed. The terms “comprising,” “including,” “containing”, “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Where devices or methods “comprise” or “contain” certain features or steps, such devices or methods may also “consist essentially of’ such features or steps if identified as such in the claims. Where devices or methods “comprise” or “contain” certain features or steps, such devices or methods may also “consist” of such features or steps if identified as such in the claims. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Further, the term “each,” as used herein, in addition to having its ordinary meaning, can mean any subset of a set of elements to which the term “each” is applied.

[0120] Language such as “up to,” “at least,” “greater than,” “less than,” “between,” and the like includes the number recited. Numbers preceded by a term such as “about” or “approximately” include the recited numbers and should be interpreted based on the circumstances (e.g., as accurate as reasonable under the circumstances). The terms “approximately”, “about”, “generally,” and “substantially” include the number after such term. For example, “about 200 Hz” includes support for the value 200 Hz.

[0121] Although certain embodiments and examples have been described herein, many aspects of the systems and devices shown and described in the present disclosure may be differently combined and / or modified to form still further embodiments or acceptable examples. All suchmodifications and variations are intended to be included herein within the scope of this disclosure.

[0122] Any methods disclosed herein need not be performed in the order recited. The methods disclosed herein may include certain actions taken by a practitioner; however, they can also include any third-party instruction of those actions, either expressly or by implication.

[0123] The methods and tasks described herein may be performed and fully automated by a computer system (e.g., one or more processors). The computer system may, in some cases, include multiple distinct computers or computing devices (e.g., physical servers, workstations, storage arrays, cloud computing resources, etc.) that communicate and interoperate over a network to perform the described functions. Each such computing device typically includes a processor (or multiple processors) that executes program instructions or modules stored in a memory or other non-transitory computer-readable storage medium or device (e.g., solid state storage devices, disk drives, etc.). The various functions disclosed herein may be embodied in such program instructions, and / or may be implemented in application-specific circuitry (e.g., ASICs or FPGAs) of the computer system. Where the computer system includes multiple computing devices, these devices may, but need not, be co-located. The results of the disclosed methods and tasks may be persistently stored by transforming physical storage devices, such as solid state memory chips and / or magnetic disks, into a different state. The computer system may be a cloud-based computing system whose processing resources are shared by multiple distinct business entities or other users.

[0124] Depending on the embodiment, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (for example, not all described operations or events are necessary for the practice of the algorithm). Moreover, in certain embodiments, operations or events can be performed concurrently, e.g., through multi -threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially.

[0125] Various illustrative logical blocks, modules, routines, and algorithm steps that may be described in connection with the disclosure herein can be implemented as electronic hardware (e.g., ASICs or FPGA devices), computer software that runs on general purpose computer hardware, or combinations of both. Various illustrative components, blocks, and steps may bedescribed herein generally in terms of their functionality. Whether such functionality is implemented as specialized hardware versus software running on general -purpose hardware depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.

[0126] The elements of any method, process, routine, or algorithm described in connection with the disclosure herein can be embodied directly in hardware, in a software module executed by a processor device, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of a non-transitory computer-readable storage medium. An example storage medium can be coupled to the processor device such that the processor device can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor device. The processor device and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor device and the storage medium can reside as discrete components in a user terminal.

Claims

CLAIMS:

1. A system for applying electrical nerve stimulation, comprising:a waveform generating unit configured to generate an electrical waveform; and an electrode arrangement for placement in electrical contact with a subject, the electrode arrangement configured to apply electrical stimulation to the subject based on the generated waveform, wherein:the generated waveform comprises a high frequency component and a lower frequency modulating envelope,the high frequency component has a dominant frequency of at least 500Hz, the modulating envelope defines a sequence of pulses, each pulse having a leading portion and a trailing portion,a duration of the leading portion of each pulse extends from a leading-portion- start time at which an amplitude of the pulse starts to rise from substantially zero to a leading-portion-end time at which the amplitude of the pulse first reaches a maximum amplitude of the pulse, andthe leading portion of the pulse comprises at least 5 periods of the dominant frequency of the high frequency component.

2. The system of claim 1 , wherein an average rate of increase of amplitude of the pulse during the leading portion is at least 10% of the maximum amplitude divided by the duration of the leading portion.

3. The system of claim 1 or 2, wherein the amplitude of the pulse increases by less than 20% of the maximum amplitude of the pulse during each period of the high frequency component during the leading portion.

4. The system of any preceding claim, wherein the system is configured to transcutaneously stimulate the hypoglossal nerve to treat an obstructed airway.

5. The system of any preceding claim, wherein a duration of the trailing portion of each pulse extends from a trailing-portion-start time at which the amplitude of the pulse is last at the maximum amplitude of the pulse to a trailing-portion-end time at which the amplitude of the pulse first reaches substantially zero again.

6. The system of claim 5, wherein the duration of the trailing portion is smaller than the duration of the leading portion, optionally at least 10 times smaller.-26-7. The system of any preceding claim, wherein the pulse duration of each pulse is defined as the time between the leading-portion-start time and the trailing-portion-end time.

8. The system of claim 7, wherein the pulse duration of each pulse is at least 5 times smaller than an average pulse periodicity of the sequence of pulses.

9. The system of claim 7 or 8, wherein the pulse duration of each pulse is at least 500 microseconds.

10. The system of any preceding claim, wherein a second derivative of the amplitude of the pulse against time is non-zero for at least a majority of the duration of the leading portion.

11. The system of claim 10, wherein a second derivative of the amplitude of the pulse against time is positive for at least a majority of a first half of the duration of the leading portion.

12. The system of claim 10 or 11, wherein a second derivative of the amplitude of the pulse against time is negative for at least a majority of a second half of the duration of the leading portion.

13. The system of any preceding claim, wherein at least the leading portion of each pulse comprises a portion of a Gaussian.

14. The system of any of claims 1-9, wherein a second derivative of the amplitude of the pulse against time is substantially zero for at least a majority of the duration of the leading portion.

15. The system of any preceding claim, wherein, for each pulse, the amplitude of the pulse increases monotonically during the leading portion of the pulse.

16. The system of any preceding claim, wherein, for each pulse, the amplitude of the pulse decreases monotonically during the trailing portion of the pulse.

17. The system of any preceding claim, wherein the dominant frequency of the high frequency component is less than 20kHz.

18. A method of applying electrical nerve stimulation, comprising:using an electrode arrangement to apply electrical stimulation to a subject based on a generated waveform, wherein:the generated waveform comprises a high frequency component and a lower frequency modulating envelope,the high frequency component has a dominant frequency of at least 500Hz,the modulating envelope defines a sequence of pulses, each pulse having a leading portion and a trailing portion,a duration of the leading portion of each pulse extends from a leading- portion-start time at which an amplitude of the pulse starts to rise from substantially zero to a leading-portion-end time at which the amplitude of the pulse first reaches a maximum amplitude of the pulse, andthe leading portion of the pulse comprises at least 5 periods of the dominant frequency of the high frequency component.

19. The method of claim 18, wherein:an average rate of increase of amplitude of the pulse during the leading portion is at least 10% of the maximum amplitude divided by the duration of the leading portion; and / or the amplitude of the pulse increases by less than 20% of the maximum amplitude of the pulse during each period of the high frequency component during the leading portion.

20. The method of claim 18 or 19, wherein:the applied electrical stimulation is for stimulating motor nerve fibres to cause muscle contraction, optionally for causing elevation of the hyoid for the purpose of treating obstructive sleep apnea; orthe applied electrical stimulation is for pain treatment, optionally spinal cord stimulation.

21. The method of claim 18 or 19, wherein the method is configured to transcutaneously stimulate the hypoglossal nerve to treat an obstructed airway.

22. A system for providing an electrical stimulation to a subject, the system comprising:a waveform generating unit, andan electrode operatively connected to the waveform generating unit and configured to provide an electrical stimulation to the subject,wherein the electrical stimulation comprises a high frequency component and a lower frequency modulating envelope,wherein the high frequency component has a dominant frequency of at least 500Hz, wherein the modulating envelope defines a pulse comprising a leading portion and a trailing portion, andwherein the leading portion of the pulse comprises at least 5 periods of the high frequency component.

23. The system of claim 22, wherein the system is configured to transcutaneously stimulate the hypoglossal nerve to treat an obstructed airway.

24. A system for providing an electrical stimulation to a subject, the system comprising:an electrode, anda waveform generating unit comprising a processor configured to provide an electrical stimulation with the electrode to the subject,wherein the electrical stimulation comprises a high frequency component and a lower frequency modulating envelope,wherein the high frequency component has a dominant frequency of at least 500Hz, wherein the modulating envelope defines a pulse comprising a leading portion and a trailing portion, andwherein the leading portion of the pulse comprises at least 5 periods of the high frequency component.

25. The system of any of claims 22 to 24, wherein the electrical stimulation is configured to produce a sustained muscle contraction with minimal synchronised nerve stimulation when the electrical stimulation is provided to the subject with the electrode.

26. The system of any of claims 22-25, wherein the leading portion of the pulse is a portion of the pulse during which the modulating envelope continuously increases in amplitude.

27. The system of claim 26, wherein the continuous increase in amplitude is configured to be gradual enough to reduce or avoid discomfort by reducing or avoiding synchronised nerve stimulation.

28. The system of any of claims 22-27, wherein the modulating envelope defines a sequence of the pulses.

29. The system of any of claims 24 to 28, wherein the system is configured to transcutaneously stimulate the hypoglossal nerve to treat an obstructed airway.-29-